🌐 Live from the web
Updated 10/20/2026Market news
The breakthroughs, deals and approvals moving the bio-economy — tracked across every sector, updated daily.
All sectors🧬 Biotech🍽️ Food-tech🌱 Agri-tech🦠 Probiotics💊 Personalized Medicine⚗️ Bioprocessing📈 Biotech Investment🔬 Research & Academia🏛️ Policy & Strategy🤖 AI in Biotech
📈 Biotech InvestmentOct 19, 2026
TriGemX Bio is going public through SPAC to get its migraine prospect to market
Read at Endpoints News →📈 Biotech InvestmentOct 19, 2026
Germany’s Medical Biotechnology Sector is Flourishing
Read at PharmTech.com →📈 Biotech InvestmentOct 19, 2026
Investment firm TCGX picks migraine biotech TriGemX to take public via SPAC
Read at Fierce Biotech →📈 Biotech InvestmentOct 19, 2026
Migraine biotech TriGemX to go public via SPAC merger with $246M in proceeds
Read at Dealroom →📈 Biotech InvestmentOct 20, 2026